Withdrawal Risk in a Combined Alcohol–Benzodiazepine Presentation
Denise, 29, walks into your outpatient program at 10 a.m. self-referred. She last drank at midnight (about 10 hours ago) and last took alprazolam - prescribed at 2 mg four times daily for four years by her primary care physician - at 6 a.m. She is tremulous and diaphoretic; pulse 114, blood pressure 148/94, CIWA-Ar 15. She denies hallucinations, has no history of seizures or delirium tremens, and denies suicidal ideation. She lives with her sister, has reliable transportation and private insurance, and has two prior outpatient attempts that each ended within three weeks. No children in the home.
1. What level of care does Denise need today, and which specific findings drive that determination?
Read the worked answer
Answer: medically monitored inpatient withdrawal management, not outpatient.
Reasoning by dimension
- Intoxication/withdrawal (Dimension 1) is where the decision is made. She is in moderate withdrawal right now (CIWA-Ar 15) with autonomic instability, and she is withdrawing from two agents at once. Alcohol and benzodiazepines act on the same receptor system, so combined dependence produces more severe withdrawal than either alone, with real seizure and delirium risk.
- Timing matters more than her current appearance. Alcohol withdrawal peaks at roughly 24–72 hours - she is only 10 hours in and will get worse, likely overnight. Benzodiazepine withdrawal emerges later still, over days to weeks. Sending her home from an outpatient office during the peak window is the unsafe choice, regardless of her CIWA score this morning.
- Biomedical (Dimension 2): no unstable medical condition reported, so she does not automatically need medically managed intensive inpatient care; but she needs 24-hour nursing observation with physician availability.
- Relapse potential (Dimension 5): two failed outpatient attempts is a strong signal that outpatient alone has not held her.
Practically: arrange immediate transfer with a documented handoff including her alprazolam dose and last dose time. Never advise abrupt benzodiazepine discontinuation - this requires a prescriber-directed taper.
2. The alprazolam was prescribed by her PCP. What is your role regarding that prescription, and what do you do?
Read the worked answer
Your role is coordination and advocacy, not pharmacology.
- Do not tell Denise to stop or cut the alprazolam, and do not suggest a specific taper schedule. Abrupt cessation of a 2 mg QID, four-year benzodiazepine regimen can cause seizures and is potentially fatal.
- Obtain a written consent that meets 42 CFR Part 2 requirements before speaking with the prescriber. SUD treatment records have stricter protections than general medical records; a standard HIPAA authorization may not be sufficient.
- Contact the prescriber the same day to share that Denise is in withdrawal management for alcohol, that she is on a high-dose long-standing benzodiazepine, and that the withdrawal management provider needs to assume or coordinate the taper. Frame it as handoff, not criticism.
- Flag the clinical concern factually, in the record and to the receiving provider: long-term high-dose benzodiazepine prescribing plus heavy alcohol use is a significant risk combination. Your job is to surface it to the people who can act on it.
- If Denise refuses consent, you cannot contact the PCP. Document the refusal, explain why coordination matters, and offer to revisit. Her refusal does not stop you from recommending the appropriate level of care.
- The receiving withdrawal management provider decides the taper regimen; you reinforce it and monitor adherence afterward.
3. Denise refuses inpatient withdrawal management and insists on outpatient because she cannot miss work. What do you do?
Read the worked answer
Refusal is not the end of the episode, and it is not grounds for punitive discharge.
1. Assess capacity and safety first. Is she oriented and able to weigh risk? Does she have someone who can stay with her tonight? Is her sister available? If she is confused or increasingly symptomatic, capacity is a live question and emergency evaluation takes precedence.
2. Explore the objection rather than debating the recommendation. "What would need to be true for you to do this?" Work/knowledge of the plan, fear of losing the job, childcare, cost. Some barriers can be solved (FMLA paperwork, a shorter stay, a same-day bed); the ones that cannot be solved still get documented.
3. Make a concrete safety plan if she leaves. Same-day or next-morning re-contact, a responsible adult with her for the next 48–72 hours, explicit written instructions on when to call 911 (seizure, confusion, hallucinations, chest pain, inability to keep fluids down), and a clear statement that she can return at any hour.
4. Document thoroughly. The level of care recommended and why, the risks explained in plain language, her stated reasons for refusing, her plan, and who was contacted. Note that she was given the opportunity to ask questions.
5. Consult your supervisor the same day. This is a high-risk decision that should not rest on one clinician's shoulders, and you want the consultation in the record.
6. Do not close the case. Continued engagement, even at a lower level of care than you believe appropriate, is safer than discharge.